If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox not checked

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D




Comment for Type of Reporting Person:
(1) Includes 993,119 shares of restricted and unrestricted Common Stock with respect to which Jason Reese has waived his voting rights pursuant to a voting waiver agreement dated as of October 29, 2024 (as described in Item 4 of Amendment No. 12 to this Schedule 13D), which voting rights may be acquired for beneficial ownership purposes within 60 days of the date of this Schedule 13D. (2) Includes 65,765 shares of Common Stock that Mr. Reese has the right to acquire upon the vesting of restricted stock within 60 days of the date of this Schedule 13D.


SCHEDULE 13D


 
Imperial Capital Asset Management, LLC
 
Signature:By: /s/ Jason Reese
Name/Title:Jason Reese, Chairman & CEO
Date:09/09/2025
 
Long Ball Partners, LLC
 
Signature:By: /s/ Jason Reese
Name/Title:By: Imperial Capital Asset Management, LLC its Managing Member, Jason Reese, Chairman & CEO
Date:09/09/2025
 
Imperial Capital Group Holdings II, LLC
 
Signature:By: /s/ Jason Reese
Name/Title:Jason Reese, its Authorized Signatory
Date:09/09/2025
 
Jason Reese
 
Signature:/s/ Jason Reese
Name/Title:To Come
Date:09/09/2025